Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Common genetic variants in candidate genes and risk of familial lymphoid malignancies.

Liang XS, Caporaso N, McMaster ML, Ng D, Landgren O, Yeager M, Chanock S, Goldin LR.

Br J Haematol. 2009 Aug;146(4):418-23. doi: 10.1111/j.1365-2141.2009.07790.x. Epub 2009 Jul 1.

2.

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.

Kristinsson SY, Björkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O.

Blood. 2008 Oct 15;112(8):3052-6. doi: 10.1182/blood-2008-06-162768. Epub 2008 Aug 13.

3.

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A.

Lancet Oncol. 2006 Jan;7(1):27-38.

PMID:
16389181
4.

Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.

Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG, Melis M, Gabbas A, Serpe R, Madeddu C, Scarpa A, Cocco P.

Hematol Oncol. 2008 Jun;26(2):98-103. doi: 10.1002/hon.843.

PMID:
18271063
5.

Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.

Kuppusamy H, Ogmundsdottir HM, Baigorri E, Warkentin A, Steingrimsdottir H, Haraldsdottir V, Mant MJ, Mackey J, Johnston JB, Adamia S, Belch AR, Pilarski LM.

PLoS One. 2014 Jun 20;9(6):e100691. doi: 10.1371/journal.pone.0100691. eCollection 2014.

6.

Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.

Goldin LR, Caporaso NE.

Br J Haematol. 2007 Dec;139(5):774-9. Review.

PMID:
18021091
7.

IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma.

Broderick P, Cunningham D, Vijayakrishnan J, Cooke R, Ashworth A, Swerdlow A, Houlston R.

Br J Haematol. 2010 Feb;148(3):413-5. doi: 10.1111/j.1365-2141.2009.07946.x. Epub 2009 Oct 5.

PMID:
19804451
8.

Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia.

Lech-Maranda E, Mlynarski W, Grzybowska-Izydorczyk O, Borowiec M, Pastorczak A, Cebula-Obrzut B, Klimkiewicz-Wojciechowska G, Wcislo M, Majewski M, Kotkowska A, Robak T, Warzocha K.

Genes Chromosomes Cancer. 2013 Mar;52(3):287-96. doi: 10.1002/gcc.22028. Epub 2012 Dec 8.

PMID:
23225254
9.

Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.

Enjuanes A, Benavente Y, Bosch F, Martín-Guerrero I, Colomer D, Pérez-Alvarez S, Reina O, Ardanaz MT, Jares P, García-Orad A, Pujana MA, Montserrat E, de Sanjosé S, Campo E.

Cancer Res. 2008 Dec 15;68(24):10178-86. doi: 10.1158/0008-5472.CAN-08-2221.

10.

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.

Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E, Lan Q, Foretova L, Schenk M, Spinelli JJ, Slager SL, De Roos AJ, Smith MT, Roman E, Cozen W, Boffetta P, Kricker A, Zheng T, Lightfoot T, Cocco P, Benavente Y, Zhang Y, Hartge P, Linet MS, Becker N, Brennan P, Zhang L, Armstrong B, Smith A, Shiao R, Novak AJ, Maynadie M, Chanock SJ, Staines A, Holford TR, Holly EA, Rothman N, Wang SS.

Am J Epidemiol. 2010 Feb 1;171(3):267-76. doi: 10.1093/aje/kwp383. Epub 2010 Jan 4.

11.

Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.

Chng WJ, Schop RF, Price-Troska T, Ghobrial I, Kay N, Jelinek DF, Gertz MA, Dispenzieri A, Lacy M, Kyle RA, Greipp PR, Tschumper RC, Fonseca R, Bergsagel PL.

Blood. 2006 Oct 15;108(8):2755-63. Epub 2006 Jun 27.

12.

Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.

Fernberg P, Chang ET, Duvefelt K, Hjalgrim H, Eloranta S, Sørensen KM, Porwit A, Humphreys K, Melbye M, Ekström Smedby K.

Cancer Causes Control. 2010 May;21(5):759-69. doi: 10.1007/s10552-010-9504-y. Epub 2010 Jan 20.

PMID:
20087644
13.

Cytogenetics in CLL and related disorders.

Juliusson G, Gahrton G.

Baillieres Clin Haematol. 1993 Dec;6(4):821-48. Review.

PMID:
8038492
14.

Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes.

Slager SL, Camp NJ, Conde L, Shanafelt TD, Achenbach SJ, Rabe KG, Kay NE, Novak AJ, Call TG, Bracci PM, Sille FM, Sanchez S, Akers NK, Cunningham JM, Serie DJ, McDonnell SK, Leis JF, Wang AH, Weinberg JB, Glenn M, Link B, Vachon CM, Lanasa MC, Skibola CF, Cerhan JR.

Br J Haematol. 2012 Dec;159(5):572-6. doi: 10.1111/bjh.12070. Epub 2012 Oct 1.

15.

The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.

Yalçın S, Mutlu P, Çetin T, Sarper M, Özgür G, Avcu F.

Turk J Haematol. 2015 Dec;32(4):311-6. doi: 10.4274/tjh.2014.0126. Epub 2014 May 21.

17.

Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.

Law PJ, Sud A, Mitchell JS, Henrion M, Orlando G, Lenive O, Broderick P, Speedy HE, Johnson DC, Kaiser M, Weinhold N, Cooke R, Sunter NJ, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Carmichael J, Bailey JR, Pratt G, Rahman T, Pepper C, Fegan C, von Strandmann EP, Engert A, Försti A, Chen B, Filho MI, Thomsen H, Hoffmann P, Noethen MM, Eisele L, Jöckel KH, Allan JM, Swerdlow AJ, Goldschmidt H, Catovsky D, Morgan GJ, Hemminki K, Houlston RS.

Sci Rep. 2017 Jan 23;7:41071. doi: 10.1038/srep41071.

18.

[Inheritance in lymphoproliferative disorders].

Jønsson V, Olsen JH.

Ugeskr Laeger. 2006 Jun 12;168(24):2361-6. Review. Danish.

PMID:
16822421
19.

Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.

Slager SL, Achenbach SJ, Asmann YW, Camp NJ, Rabe KG, Goldin LR, Call TG, Shanafelt TD, Kay NE, Cunningham JM, Wang AH, Weinberg JB, Norman AD, Link BK, Leis JF, Vachon CM, Lanasa MC, Caporaso NE, Novak AJ, Cerhan JR.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):461-6. doi: 10.1158/1055-9965.EPI-12-1217. Epub 2013 Jan 10.

20.

Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma.

da Silva GN, Bacchi MM, Rainho CA, de Oliveira DE.

Arch Pathol Lab Med. 2007 Nov;131(11):1691-6.

PMID:
17979488

Supplemental Content

Support Center